Vertex Pharmaceuticals

vrtx.com

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ 2,100 people in the United States, Europe, Canada and Australia with nearly two-thirds of our staff dedicated to research and development. Vertex is consistently recognized as one of the industry’s top places to work by Science magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Fench Prix Galien and the British Pharmacological Society awards.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Raw Materials

TECHNIPAQ PARTNERS WITH DUPONT TYVEK AND FREEPOINT ECO-SYSTEMS TO REDUCE AND RECYCLE MEDICAL PACKAGING PLASTIC WASTE

Technipaq& DuPont & Tyvek | September 20, 2021

news image

Technipaq Inc., a leading manufacturer of flexible sterilizable packaging solutions and Tyvek Authorized Converter, proudly announces a new partnership with DuPont Tyvek and recycling partner Freepoint Eco-Systems, designed to significantly build upon the company's ongoing sustainability and recycling efforts. Commencing on World Cleanup Day (Sept. 18, 2021), Technipaq will be able to effectively divert its mixed material plastic waste stream, containing Tyvek® and other p...

Read More

CALIFORNIA TESTING HAMSTRUNG BY SHORTAGE OF KEY CHEMICAL

Daily Democrat | March 17, 2020

news image

California’s rush to detect new cases of COVID-19 has been slowed by shortages of a key chemical needed to conduct the diagnostic tests, Gov. Gavin Newsom said Thursday. And because of this shortage, the federal government has restrictions on who gets tested, even as the cases and deaths mount. “My great concern is we could be testing a lot more people,” said Newsom. California now has 8,227 test kits sent by the U.S. Centers for Disease Control and Prevention, he said. The kit...

Read More

MANUFACTURER TO ACQUIRE GLOBAL CHEMICALS COMPANY

Medical Plastics News | January 21, 2020

news image

Borchers who are headquartered in Westlake, Ohio possess a portfolio of additives for the coatings, inks and adhesives markets with a comprehensive range of cobalt-free driers, dispersants, rheology modifiers, wetting agents, polymerisation catalysts and adhesion promoters. This acquisition will result in Milliken gaining Borchers’ expertise in specialty coating additives, to further build on its portfolio, as well as aligning with the company’s strategic objective to develop a globa...

Read More

OECD PLANS SURVEYS TO QUANTIFY BENEFITS OF CHEMICALS REGULATION

Chemical Watch | January 30, 2020

news image

The OECD is in the early stages of compiling a list of best practices when assessing the economic costs and benefits of chemicals management systems. It will draft studies this year to assess the willingness of the public to pay to avoid certain adverse health effects that can result from chemical exposure. Next year, it plans to carry out these surveys for five endpoints, each from five different countries. The work is being carried out by the OECD’s working party on integrating economic ...

Read More
news image

Raw Materials

TECHNIPAQ PARTNERS WITH DUPONT TYVEK AND FREEPOINT ECO-SYSTEMS TO REDUCE AND RECYCLE MEDICAL PACKAGING PLASTIC WASTE

Technipaq& DuPont & Tyvek | September 20, 2021

Technipaq Inc., a leading manufacturer of flexible sterilizable packaging solutions and Tyvek Authorized Converter, proudly announces a new partnership with DuPont Tyvek and recycling partner Freepoint Eco-Systems, designed to significantly build upon the company's ongoing sustainability and recycling efforts. Commencing on World Cleanup Day (Sept. 18, 2021), Technipaq will be able to effectively divert its mixed material plastic waste stream, containing Tyvek® and other p...

Read More
news image

CALIFORNIA TESTING HAMSTRUNG BY SHORTAGE OF KEY CHEMICAL

Daily Democrat | March 17, 2020

California’s rush to detect new cases of COVID-19 has been slowed by shortages of a key chemical needed to conduct the diagnostic tests, Gov. Gavin Newsom said Thursday. And because of this shortage, the federal government has restrictions on who gets tested, even as the cases and deaths mount. “My great concern is we could be testing a lot more people,” said Newsom. California now has 8,227 test kits sent by the U.S. Centers for Disease Control and Prevention, he said. The kit...

Read More
news image

MANUFACTURER TO ACQUIRE GLOBAL CHEMICALS COMPANY

Medical Plastics News | January 21, 2020

Borchers who are headquartered in Westlake, Ohio possess a portfolio of additives for the coatings, inks and adhesives markets with a comprehensive range of cobalt-free driers, dispersants, rheology modifiers, wetting agents, polymerisation catalysts and adhesion promoters. This acquisition will result in Milliken gaining Borchers’ expertise in specialty coating additives, to further build on its portfolio, as well as aligning with the company’s strategic objective to develop a globa...

Read More
news image

OECD PLANS SURVEYS TO QUANTIFY BENEFITS OF CHEMICALS REGULATION

Chemical Watch | January 30, 2020

The OECD is in the early stages of compiling a list of best practices when assessing the economic costs and benefits of chemicals management systems. It will draft studies this year to assess the willingness of the public to pay to avoid certain adverse health effects that can result from chemical exposure. Next year, it plans to carry out these surveys for five endpoints, each from five different countries. The work is being carried out by the OECD’s working party on integrating economic ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us